Okta, Inc. <OKTA.O>: Wells Fargo raises target price to $150 from $100
OKTA•Related News
Adaptive Biotechnologies Chief Commercial Officer Susan Bobulsky disposes of 5,000 shares for $115,000
ADPT•
Global Markets-Stocks fall as oil gains; Iran tensions, earnings in focus
SPY•
DigitalBridge to report Q2 financial results
DBRG•
North American Construction Group schedules Q2 results release, webcast call
NOA•
Anixa Biosciences director Lewis H. Titterton Jr acquires 12,000 common shares valued at $41,640
ANIX•